Search published articles


Showing 2 results for Bacteriocins

Leila Goudarzi, Rouha Kasra Kermanshahi, Zahra Moosavi-Nejad,
Volume 10, Issue 2 (3-2016)
Abstract

ABSTRACT

        Background and Objective: Lactic acid bacteria are Gram-positive, catalase-negative, nonsporulating, either rod- or coccus-shaped bacteria that have beneficial effects on their hosts by producing antimicrobial substances such as lactic acid, hydrogen peroxide, bacteriocins and biosurfactants. Bacteriocins are antimicrobial peptides that are produced by bacteria and can inhibit the growth of other bacteria.

       Methods: In this experimental study, bacteriocin production by Lactobacilli as known probiotic strains was evaluated in different physicochemical conditions. Antagonistic activity was evaluated using quantitative method of Microscale Optical Density Assay (MODA). After neutralization of acid and treatment with various enzymes, temperature, pH and NaCl conditions, the antimicrobial activity of culture supernatant fluid of Lactobacillus acidophilus and L. plantarum was investigated against pathogenic Proteus.

       Results: The culture supernatant fluid of Lactobacilli was sensitive to proteolytic enzymes with relatively good stability to temperature. The antimicrobial activity was also present due to production of bacteriocin under different NaCl conditions (1 to 4% NaCl) and pH range of 5 to 8.

        Conclusion: It seems that the antimicrobial liquid of Lactobacillus strains contains bacteriocin, which shows antimicrobial effects against pathogenic strains of Proteus. To investigate further this effect, some complementary studies should be performed.


Saman Shalibeik, Fereshte Ghandehari, Ali-Mohammad Ahadi, Ali-Asghar Rastegari, Mojgan Ghiasian,
Volume 16, Issue 3 (5-2022)
Abstract

Background and objectives: Bacteriocins are generally active antimicrobial peptides effective against bacteria closely related to the producer. Escherichia coli produce two bacteriocins: colicins and microcins. Microcin J25 (Mcc J25) is an antibacterial peptide that inhibits bacterial transcription by disrupting the nucleotide-uptake channel of bacterial RNA polymerase. The objective of this study was to evaluate antimicrobial activity of MccJ25 produced by the bacteriocinogenic E. coli.
Methods: In this experimental study, 120 clinical specimens were selected from private diagnostic laboratories in Isfahan (Iran) in 2020. Antagonistic activity of isolates was tested by adopting agar plug method. Total DNA was extracted from clinical specimens and polymerase chain reaction (PCR) was performed using specific primers for amplification of the complete sequence of MccJ25 gene. Accuracy of the PCR products was confirmed by direct sequencing. Homology analysis was performed by using BLAST. Data were analyzed with Chromasv2.1.1 software.
Results: Overall, 120 E. coli strains were isolated from the clinical specimens. The antibiotic activity of Mcc J25 was mainly directed at Enterobacteriaceae, including several pathogenic E. coli strains of which 25 had positive well test samples, and about 5 (20%) of the collected clinical samples that were infected with E. coli had the MccJ25 gene.
Conclusions: Based on the results, Mcc J25 has favorable antibacterial potential, which can be further exploited as an alternative to chemical antibiotics.

Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.